Hansa Biopharma Year-end report January-December 2022 ...Middle East

News by : (PR Newswire) -
Total 2022 revenue of SEK 155m Cash runway extended into 2025 Market Access obtained in four of the five largest European markets Reported positive Phase 2 top-line data in AMR Decision made to initiate clinical study with imlifidase as a pre-treatment to Sarepta's SRP-9001 gene therapy...

Hence then, the article about hansa biopharma year end report january december 2022 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Hansa Biopharma Year-end report January-December 2022 )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار